Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Rational Analyst -- Ignore unavailable to you. Want to Upgrade?

To: HeyRainier who wrote (1287)	7/22/1998 10:31:00 PM
From: Scott H. Davis	Read Replies (2) \| Respond to of 1720

[EQNX Lession] The painful lesson of EQNX - when working a day job where you can't moniter things dependably, set stops, revise stops, but don't go without stops. Ouch Which brings up a question. ISIP had a great success today Isis and CIBA Vision's Drug For CMV Retinitis Receives Advisory Committee Recommendation For Approval biz.yahoo.com In after hours trading, its up $4.00, CEO was on the news tonight (1st Antisense medication recommended by an FDA panel, and with no reservations) and will be on CNBC squakbox in the AM. Serious POP in the making, with a likely pullback. With a price about $18.00 in after hours trading, should I set a stop pre-emptively in the Am and at what point? Scott